Tesamorelin
GHRH analogue with a stabilised N-terminus, studied at the GHRH receptor
7 papers · 2010–2026 · 6 journals
What the research explores
Tesamorelin is used in the literature as a stabilised comparator against native GHRH and shorter analogues. Areas of published study include:
- How N-terminal acylation affects susceptibility to dipeptidyl peptidase-4 degradation
- Receptor binding and cAMP signalling at GHRHR in pituitary-derived cell models
- Pharmacokinetic profiling of modified versus unmodified GHRH sequences in preclinical species
- Structure-activity relationships across the GHRH analogue family
- Analytical method development for separating the intact peptide from its degradation products
These describe scientific questions under investigation. They are not statements of benefit or outcome, and Elements DNA supplies this material for in vitro and preclinical laboratory use only.
References
A reference list, not evidence. Inclusion means a paper discusses the compound — not that it supports any use, and not that it describes this product.
2026
- Selected Industry Highlights From IDWeek 2025
Parienti JJ, Yang SS, Grinspoon S
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
- Selected Industry Highlights From IDWeek 2025
2021
- Advances in the detection of growth hormone releasing hormone synthetic analogs
Memdouh S, Gavrilović I, Ng K, et al.
Drug testing and analysis
- Advances in the detection of growth hormone releasing hormone synthetic analogs
2013
- Growth hormone in the aging male
Sattler FR
Best practice & research. Clinical endocrinology & metabolism
- Growth hormone in the aging male
2012
2011
- Tesamorelin
Grunfeld C, Dritselis A, Kirkpatrick P
Nature reviews. Drug discovery
- Tesamorelin
2010
- Tesamorelin update
O'Neal R
BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation
- Tesamorelin update
For laboratory and research use only · Not for human or veterinary consumption · Not evaluated by the FDA
